Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Takeshi Iwaya"'
Autor:
Takaaki, Beppu, Takeshi, Iwaya, Yuichi, Sato, Jun-Ichi, Nomura, Kazunori, Terasaki, Toshiaki, Sasaki, Noriyuki, Yamada, Shunrou, Fujiwara, Tamotsu, Sugai, Kuniaki, Ogasawara
Publikováno v:
Clinical Nuclear Medicine. 47:569-574
The aim of this study was to clarify whether PET with 11C-methyl-l-methionine (11C-met PET) can predict consequential outcomes at the time of discontinuing temozolomide (TMZ)-adjuvant chemotherapy in patients with residual isocitrate dehydrogenase ge
Autor:
Tomoko Takahashi, Takeshi Iwaya, Takashi Tokino, Satoshi Nishizuka, Yuji Akiyama, Tomomi Hirano, Masashi Idogawa, Yasushi Sasaki, Masakazu Abe, Fumitaka Endo, Akira Sasaki, Hayato Hiraki, Yuka Koizumi, Noriyuki Sasaki, Fumiaki Takahashi, Ryosuke Fujisawa, Shoichiro Tange, Mari Masuda, Mizunori Yaegashi
Publikováno v:
Carcinogenesis. 42:1239-1249
PurposeWe investigated whether early circulating tumor DNA (ctDNA) changes, measured using digital PCR (dPCR), can predict later chemotherapy responses in esophageal squamous cell cancer (ESCC).DesignWe compared the dynamics of ctDNA and tumor volume
Autor:
Doris R. Siwak, Toshimoto Kimura, Kei Sato, Hidewaki Nakagawa, Takeshi Iwaya, Masashi Fujita, Noriyuki Sasaki, Lance A. Liotta, Satoshi Nishizuka, Fumitaka Endo, Yiling Lu, Tsuyoshi Hachiya, Mizunori Yaegashi, Koki Otsuka, Tamotsu Sugai, Gordon B. Mills, Ryo Sugimoto, Zhenlin Ju
Publikováno v:
British Journal of Cancer
Background Circulating tumour DNA (ctDNA) is known as a tumour-specific personalised biomarker, but the mutation-selection criteria from heterogeneous tumours remain a challenge. Methods We conducted multiregional sequencing of 42 specimens from 14 c
Autor:
Ryunosuke Kogo, Tomomi Manako, Takeshi Iwaya, Satoshi Nishizuka, Hayato Hiraki, Yasushi Sasaki, Masashi Idogawa, Takashi Tokino, Ayaka Koide, Noritaka Komune, Ryuji Yasumatsu, Takashi Nakagawa
Publikováno v:
Cancer medicine. 11(21)
There is no useful biomarker to evaluate treatment response and early relapse in head and neck squamous cell carcinoma (HNSCC). Circulating tumor DNA (ctDNA) is a promising biomarker for detecting minimal residual diseases and monitoring treatment ef
Autor:
Hiroyuki Nitta, Toshimoto Kimura, Akira Sasaki, Takeshi Takahara, Shigeaki Baba, Yuji Akiyama, Keisuke Koeda, Koki Otsuka, Haruka Nikai, Ryosuke Fujisawa, Takeshi Iwaya, Fumitaka Endo, Noriyuki Sasaki, Yasushi Hasegawa
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-7 (2020)
World Journal of Surgical Oncology
World Journal of Surgical Oncology
Background Pylorus-preserving gastrectomy (PPG) has been accepted as a function-preserving surgery for the treatment of early gastric cancer in East Asian countries. Therefore, this study aimed to evaluate the feasibility and safety of totally laparo
Autor:
Keisuke Koeda, Akira Sasaki, Takehiro Chiba, Hiroyuki Nitta, Takeshi Takahara, Shigeaki Baba, Yuji Akiyama, Masaru Mizuno, Takeshi Iwaya, Toshimoto Kimura, Fumitaka Endo, Yusuke Kimura, Haruka Nikai, Koki Otsuka
Publikováno v:
Asian Journal of Endoscopic Surgery. 13:152-159
Introduction Recent studies have reported that induction chemotherapy with docetaxel plus cisplatin and 5-fluorouracil (DCF) is an effective treatment for unresectable, locally advanced esophageal cancer. The aim of this study was to investigate the
Autor:
Yuka, Koizumi, Sheny, Ahmad, Miyuki, Ikeda, Akiko, Yashima-Abo, Ginny, Espina, Ryo, Sugimoto, Tamotsu, Sugai, Takeshi, Iwaya, Gen, Tamura, Keisuke, Koeda, Lance A, Liotta, Fumiaki, Takahashi, Satoshi S, Nishizuka
Publikováno v:
J Natl Cancer Inst
Background Paradoxically, Helicobacter pylori–positive (HP+) advanced gastric cancer patients have a better prognosis than those who are HP–negative (HP-). Immunologic and statistical analyses can be used to verify whether systemic mechanisms mod
Autor:
Yuji Akiyama, Akira Sasaki, Hiroyuki Nitta, Akira Umemura, Takeshi Takahara, Takeshi Iwaya, Yasushi Hasegawa, Koki Otsuka, Hirokatsu Katagiri, Shoji Kanno
Publikováno v:
Journal of hepato-biliary-pancreatic sciencesREFERENCES. 27(12)
Background Indications for laparoscopic liver resection (LLR) are continuously expanding. The Japanese Society of Hepato-Biliary-Pancreatic Surgery defines highly difficult hepatectomy as a procedure involving one or more sections (except for left la
Autor:
Akira Sasaki, Ryosuke Fujisawa, Yuji Akiyama, Yukihide Nishimura, Noriyuki Sasaki, Koki Otsuka, Fumitaka Endo, Haruka Nikai, Takeshi Iwaya, Yusuke Fujii, Yasushi Hasegawa, Takeshi Takahara, Keisuke Koeda, Toshimoto Kimura, Hiroyuki Nitta, Shigeaki Baba
Publikováno v:
Esophagus : official journal of the Japan Esophageal Society. 18(1)
Several studies have demonstrated that prehabilitation helps reduce the incidence of postoperative complications. In this study, we investigated the safety and efficacy of enhanced prehabilitation (EP) in the hospital for patients with esophageal can
Autor:
Doris R. Siwak, Hidewaki Nakagawa, Takehiro Chiba, Lance A. Liotta, Zhenlin Ju, Mizunori Yaegashi, Tsuyoshi Hachiya, Takeshi Iwaya, Gordon B. Mills, Masashi Fujita, Yiling Lu, Noriyuki Sasaki, Tamotsu Sugai, Satoshi Nishizuka, Ryo Sugimoto, Fumitaka Endo
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0239966 (2020)
PLoS ONE
PLoS ONE
Circulating tumor DNA (ctDNA) is released from tumor cells into blood in advanced cancer patients. Although gene mutations in individual tumors can be diverse and heterogenous, ctDNA has the potential to provide comprehensive biomarker information. H